Growth & Performance
CJC-1295 With DAC
Choose an option
Select the amount per vial, then choose a package size.
Amount per vial
Package size
Your estimate includes a flat $65 shipping charge and an 8% transaction fee on the product subtotal. No payment is collected here.
Overview
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analogue of Growth Hormone Releasing Hormone (GHRH). The DAC modification allows it to bind to albumin in the bloodstream, dramatically extending its half-life to approximately 6-8 days compared to just minutes for natural GHRH. This enables sustained elevation of GH and IGF-1 levels with less frequent dosing. Research suggests it can significantly increase lean muscle mass, support fat loss, improve sleep quality, and enhance recovery. It is often studied alongside a GHRP like Ipamorelin for a comprehensive GH optimization protocol.
- Selected variation
- CJC-1295 With DAC
- Amount per vial
- 5mg
- Intended use
- Laboratory research only
- Route of administration
- Subcutaneous injection
Research information
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting analog of growth hormone-releasing hormone. It is designed to extend the half-life of the peptide, allowing for sustained stimulation of growth hormone release. It is primarily used in research to study the long-term effects of growth hormone modulation, with most findings based on preclinical and early-stage laboratory models.
For laboratory research only. Not for human or animal consumption. Catalog information is not medical advice or a claim of therapeutic benefit.